Biodesix, Inc. (NASDAQ:BDSX) Q4 2021 Earnings Conference Call March 14, 2022 8:30 AM ET Company Participants Scott Hutton - President & CEO Robin Harper Cowie - CFO Chris Brinzey - IR Conference Call Participants Brian Weinstein - William Blair Kyle Mikson - Canaccord Genuity Yuko Oku - Morgan Stanley Sung Ji Nam - BTIG Operator Ladies and gentlemen, thank you for standing by. Welcome to the Biodesix Fourth Quarter and Full Year 2021 Earnings Conference Call. At this time, all participants are in a listen-o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39659 Biodesix, Inc. (Exact name of Registrant as specified in its Charter) Delaware 20-3986492 (State or other jurisdiction of incor ...

| --- | --- | --- | --- | --- | --- | |------------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | Corporate Presentation | | | | | | | Third Quarter 2021 | | | | | | Disclaimer This presentation and the accompanying oral presentation have been prepared by Biodesix, Inc. ("Biodesix", "we" or the "Company") for informational purposes only and not for any other purpose. Nothing contained in this presentation is, or should be construed as, a recommendation, pro ...

Biodesix, Inc. (NASDAQ:BDSX) Q3 2021 Earnings Conference Call November 15, 2012 9:00 AM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - President and Chief Executive Officer Robin Harper Cowie - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Brian Weinstein - William Blair Kyle Mikson - Canaccord Genuity Sung Ji Nam - BTIG Operator Good day and thank you for standing by. Welcome to the Biodesix Third Quarter 2021 Earnings Conference Call. At this tim ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39659 | --- | --- | --- | |-------------------------------------------------------------------------------------------------- ...

| --- | --- | --- | --- | --- | --- | |------------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | Corporate Presentation | | | | | | | Third Quarter 2021 | | | | | | Disclaimer This presentation and the accompanying oral presentation have been prepared by Biodesix, Inc. ("Biodesix", "we" or the "Company") for informational purposes only and not for any other purpose. Nothing contained in this presentation is, or should be construed as, a recommendation, pro ...

Biodesix, Inc. (NASDAQ:BDSX) Q2 2021 Earnings Conference Call August 10, 2021 4:30 PM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowie - Chief Financial Officer Conference Call Participants Yuko Oku - Morgan Stanley Brian Weinstein - William Blair Kyle Mikson - Canaccord Genuity Operator Good day and thank you for standing by. Welcome to the Biodesix Second Quarter 2021 Financial Results and Business Update Conference Call. At this time, al ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39659 | --- | --- | --- | |------------------------------------------------------------------------------------------------------- ...

Biodesix, Inc. (NASDAQ:BDSX) Q1 2021 Earnings Conference Call May 11, 2021 4:30 PM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowie - Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanley Brian Weinstein - William Blair Sung Ji Nam - BTIG Operator Good day and thank you for standing by. Welcome to the Biodesix First Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39659 | --- | --- | --- | |------------------------------------------------------------------------------------------------------ ...